MedTrace Logo

Epione® Post-Market Clinical Follow-up Study

NCT05529979 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2026-01-06

Study results available
· View outcomes & findings →

Summary

Post-Market Clinical Follow-up study in order to consolidate performance and safety data of the EPIONE® device when used for percutaneous procedures in the abdomen

Conditions

  • Cancer Abdomen

Interventions

DEVICE

EPIONE® CT-Guided Percutaneous procedures

The EPIONE device is a user controlled, stereotactic accessory intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures.

Sponsors & Collaborators

  • Quantum Surgical

    lead INDUSTRY

Principal Investigators

  • Baptiste BONNET, MD · Gustave Roussy, Cancer Campus, Grand Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-28
Primary Completion
2023-02-22
Completion
2024-04-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05529979 on ClinicalTrials.gov